2D8-79092-18902

4 vaccinations 9 coded responses 30 check-ins 9 free-text entries 3 call cases

Sex: Female
Age at first dose: 61-65
ZIP prefix: 019 / MA
Registered: 2021-09-01

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-24
Dose 1 — Pfizer-BioNTech
2021-04-15
Dose 2 — Pfizer-BioNTech
2021-09-01
Registered in v-safe
2021-09-01
Dose 3 — Pfizer-BioNTech
2021-09-01
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-09-02
Survey response — days 1–6 daily, dose 3
MedDRA: Heart rate increased, Oedema peripheral — Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Elevated heart rate at rest, swelling under left arm.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-03
Survey response — days 1–6 daily, dose 3
MedDRA: Heart rate increased — Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: elevated heart rate at rest

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-04
Survey response — days 1–6 daily, dose 3
MedDRA: Chest pain, Painful respiration — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Chest pain, hurts to breathe deeply

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-05
Survey response — days 1–6 daily, dose 3
MedDRA: Chest pain, Painful respiration — Feeling: Poor · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Chest pain especially when breathing

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-06
Survey response — days 1–6 daily, dose 3
MedDRA: Chest pain, Hypopnoea, Palpitations — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: palpitations, chest pain for even shallow breaths

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-07
Survey response — days 1–6 daily, dose 3
MedDRA: Heart rate increased, Painful respiration, Ventricular extrasystoles — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: PVCs, elevated HR, severe chest pain when breathing

MedDRA releases: 2024-11 · check-in free text available
2021-09-07
Report sent to call center — days 1–6 daily, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-09-08
Survey response — day 7, dose 3
MedDRA: Chest pain, Heart rate increased, Painful respiration, Palpitations — Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Chest pain when breathing, elevated HR, palpitations

MedDRA releases: 2024-11 · check-in free text available
2021-09-08
Report sent to call center — day 7, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-09-13
Call successful
Participant prefers to complete VAERS report online
2021-09-15
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2021-09-22
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2021-09-29
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2021-10-06
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2021-10-13
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2021-12-01
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-03-02
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-05-16
Dose 4 — Pfizer-BioNTech
2022-05-16
Health check-in — day 0, dose 4
Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2022-05-17
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain, Redness · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-05-19
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches

Adult check-in
2022-05-20
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-05-21
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2022-05-22
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2022-05-23
Health check-in — day 7, dose 4
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-05-30
Survey response — day 14, dose 4
MedDRA: Ocular hyperaemia — Feeling: Fair

Free text: I have developed badly bloodshot eyes.

MedDRA releases: 2024-11 · check-in free text available
2022-06-06
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-06-13
Survey response — day 28, dose 4
MedDRA: Atrial fibrillation, Hospitalisation, Pericarditis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization

Free text: I had the Evusheld treatment & landed in the hospital with a big pericarditis episode and atrial fibrillation.

MedDRA releases: 2024-11 · check-in free text available
2022-06-13
Report sent to call center — day 28, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-06-14
Call 1 — Left Voicemail
2022-06-14
Call 1 — Left Voicemail
2022-06-14
Call 1 — Left Voicemail
2022-06-20
Health check-in — day 35, dose 4
Feeling: Fair

Adult check-in
2022-06-27
Health check-in — day 42, dose 4
Feeling: Fair

Adult check-in
2022-08-15
Health check-in — 3 months, dose 4
Feeling: Fair

Adult check-in
2022-11-16
Health check-in — 6 months, dose 4
Feeling: Fair

Adult check-in
2023-05-16
Health check-in — 12 months, dose 4
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-24	Pfizer-BioNTech	No
2	2021-04-15	Pfizer-BioNTech	No
3	2021-09-01	Pfizer-BioNTech	No
4	2022-05-16	Pfizer-BioNTech	No

Call center

3 call center cases

2 successful · 1 unsuccessful

2 waits over 3 months for a first call

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 3

2021-09-02

Systemic reaction (other): Elevated heart rate at rest, swelling under left arm.

2021-09-03

Systemic reaction (other): elevated heart rate at rest

2021-09-04

Systemic reaction (other): Chest pain, hurts to breathe deeply

2021-09-05

Systemic reaction (other): Chest pain especially when breathing

2021-09-06

Systemic reaction (other): palpitations, chest pain for even shallow breaths

2021-09-07

Systemic reaction (other): PVCs, elevated HR, severe chest pain when breathing

Release 9 — day 7, dose 3

2021-09-08

Systemic reaction (other): Chest pain when breathing, elevated HR, palpitations

Release 11 — day 14, dose 4

2022-05-30

Symptoms: I have developed badly bloodshot eyes.

Release 12 — day 28, dose 4

2022-06-13

Symptoms: I had the Evusheld treatment & landed in the hospital with a big pericarditis episode and atrial fibrillation.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Atrial fibrillation	·	·	✓
SD	Hospitalisation	·	·	✓
SD	Ocular hyperaemia	·	·	✓
SD	Pericarditis	·	·	✓
SRO	Chest pain	✓	·	✓
SRO	Heart rate increased	✓	·	✓
SRO	Hypopnoea	✓	·	✓
SRO	Oedema peripheral	✓	·	✓
SRO	Painful respiration	✓	·	✓
SRO	Palpitations	✓	·	✓
SRO	Ventricular extrasystoles	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release